Biofeedback measurement instruments are used to monitor various physiological activities like muscle movement, brain activities, heart function, breathing patterns and skin conditions. These instruments provide visual or auditory feedback to a person and help them to voluntarily control these bodily functions. They are finding increasing applications in pain management, stress management, hypertension treatment and rehabilitation of stroke patients. The growing adoption of biofeedback therapy to treat various medical conditions is driving the demand for these instruments.

The global biofeedback measurement instrument market is estimated to be valued at US$ 213.59 million in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.

Growing awareness about numerous benefits of Biofeedback Measurement Instrument Market Trends and increasing inclination towards non-pharmacological treatments are some of the major factors pushing the adoption of these instruments across healthcare sector. However, dearth of skilled professionals and limited insurance coverage in some countries may restrain the market growth.

Key Takeaways
Key players operating in the biofeedback measurement instrument market are HIPRA, VETERQUIMICA SA, Ictyogroup, Kyoto Biken Laboratories, Inc., Vaxxinova International BV, Barramundi Group, Merck & Co., Inc., Zoetis Inc., KBNP, INC., Aqua Vet S.A., and NISSEIKEN CO., LTD. These companies are focusing on new product launches and enhancing their global presence through strategic partnerships and collaborations.

The growing demand for biofeedback therapy in management of stress, chronic pain and hypertension is augmenting the demand for associated measurement instruments. Various clinical studies have demonstrated the effectiveness of biofeedback in treatment of mental health conditions like depression and anxiety. This is encouraging more patients to opt for it.

Get More Insights on- Biofeedback Measurement Instrument Market